Sutro Biopharma (STRO) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $20.47
• Market Cap: $79.09M
• EPS: $-2.60
• 52-Week High: $20.47
• 52-Week Low: $5.23

Market Sentiment

Sutro Biopharma currently has a Bullish sentiment score of 0.16.

About Sutro Biopharma

Sutro Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and manufacturing of innovative antibody-drug conjugates (ADCs) using its proprietary cell-free protein synthesis platform. Based in South San Francisco, California, Sutro is committed to advancing a robust pipeline of targeted therapies for cancer and other serious diseases. With its unique capabilities in protein engineering and biologics manufacturing, the company aims to address unme...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Sutro Biopharma and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does STRO pay dividends?

Sutro Biopharma (STRO) does not currently pay a regular dividend.

What is STRO's market cap?

Sutro Biopharma (STRO) has a market capitalization of $79.09M with a current stock price of $20.47.